Navigation Links
MedImmune To Present Seven Posters On Influenza, Respiratory Syncytial Virus At The Annual Pediatric Academic Societies Meeting

GAITHERSBURG, Md., May 4, 2013 /PRNewswire/ -- MedImmune announced today it will conduct seven poster and/or presentations at the Pediatric Academic Societies (PAS) Meeting at the Walter E. Washington Convention Center in Washington DC, May 4-7, 2013.  These abstracts advance the body of existing data and knowledge around influenza and respiratory syncytial virus (RSV) prevention, highlighting MedImmune's continued commitment to patient health.

MedImmune posters to be presented at PAS regarding influenza include:

  • Efficacy of Live Attenuated Influenza Vaccine Against Moderate to Severe Versus Mild Influenza Illness in Children. Ambrose CS, Wu X, Belshe RB. Platform Presentation Session: May 4, 2013, 9:45 AM, Session: Section 115- Infectious Diseases, Vaccines & Infections 

  • Serum HAI Antibody Response to LAIV in 2 to 49 Year Olds.Coelingh K, Wu X, Mallory R, Ambrose CS. Poster Session: May 4, 2013, 1:00 PM – 4:00 PM; Exhibit Hall D/E; Board: 493

MedImmune posters to be presented at PAS regarding RSV include:

  • Burden of and Risk Factors for Medically Attended RSV Illness in 32−35 w/GA Infants Not Receiving RSV Prophylaxis. Groothuis J, Wu X, Makari D, Ambrose CS.  Poster Session: May 4, 2013, 1:00 pm− 4:00 pm, Publication Number: 1500.4. Session: 1500 – Epidemiology, Exhibit Hall D/E, Board: 4

  • Risk for Medically Attended RSV Illness in 32−34 Weeks vs. 35 Weeks Gestational Age Preterm Infants Not Receiving Palivizumab.  Groothuis J, Wu X, Makari D, Ambrose CS.  Publication Number 1500.3.  Poster Session: May 4, 2013, 1:00 pm− 4:00 pm. Session: 1500 – Epidemiology, Exhibit Hall D/E, Board: 3 

  • Respiratory Syncytial Virus Surveillance, 2007–2012: Results from RSVAlert®, a U.S. National Hospital-Based Surveillance Program. Boron M, Kumar V, McGuiness CB, Saunders B, Rabon-Stith K .  Poster Session: May 4, 2013, 1:00 pm− 4:00 pm, Publication Number: 1500.7, Session: 1500 – Epidemiology, Exhibit Hall D/E, Board: 7

  • Impact of Partial Prophylaxis with Palivizumab on RSV Hospitalizations among Commercially-Insured High-Risk Preterm Infants. Ryan K, Stewart D, Frogel M, Becker L, Pinsky B. Poster Session : May 5, 2013, 4:15 pm− 7:30 pm. Publication Number: 2915.209. Session: 2915 − Infectious Diseases, Exhibit Hall D/E, Board: 209

  • Pharmacokinetic (PK) Profile of Palivizumab (Pali) in Premature Infants. La Via WV, Makari D, Yu X, Robbie GJ. Poster Session: May 7, 2013, 10:00 am− 2:00 pm. Publication Number: 4514.228.  Session: 4514 − Neonatal Infectious Diseases / Immunology, Exhibit Hall D/E, Board: 228

Additional information about the 2013 PAS conference can be found at 

About MedImmune 
MedImmune is the worldwide biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines.  MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines.  MedImmune has approximately 2,500 employees globally, with its headquarters located in Gaithersburg, Md., one of AstraZeneca's three global R&D centers.  For more information, please visit

SOURCE MedImmune
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic for Chinese Market
2. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
3. Boston Scientific Schedule of Major Events and Presentations at Heart Rhythm 2013
4. Heska Corporation to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
5. Zimmer Holdings to Present at Deutsche Bank Securities Annual Health Care Conference
6. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
7. Ferring Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologists Annual Clinical Meeting
8. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
9. XBiotech to Present at UBS Global Healthcare Conference
10. Leonhardt Ventures to Present Technology Showcase @ Heart Rhythm 2013
11. Vatsala Naageshwaran of Absorption Systems to Present at Disso 2013 International Conference in Mumbai, India on May 3rd
Post Your Comments:
(Date:11/27/2015)... 27, 2015 Research and Markets ( ... Intrauterine Devices Market 2015-2019" report to their offering. ... In this report, the author the present scenario and ... 2015-2019. To calculate the market size, the report considers ... products: Hormonal IUDs and copper IUDs. The report forecasts ...
(Date:11/26/2015)... India , November 27, ... --> --> ... personal emergency response system (PERS) ... steadily for 5 years with ... region expected to see a ...
(Date:11/26/2015)... North Carolina , 26 november 2015 ... Inc. (AAIPharma/CML) kondigt de geplande investering aan ... uitbreiding van de laboratoria en het mondiale ... . De uitbreiding zal resulteren in extra ... wordt voldaan aan de groeiende behoeften van ...
Breaking Medicine Technology:
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... ... exchange technology and teleradiology services, has added Chris Hafey and Claude Hooton to ... at the Radiological Society of North America (RSNA) 2015 Annual Meeting and continues ...
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... PA (PRWEB) , ... November 27, 2015 , ... ... how filthy the toilets were," said an inventor from Hillside, N.J. "Many people ... improved seat cover so that individuals will always be protected from germs." , ...
(Date:11/27/2015)... LOS ANGELES, CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only ... age of 30 (see Table 1-1 ). More than 3.7 billion people under ... simplex virus type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection ...
Breaking Medicine News(10 mins):